BBC3 and cancer: Amplification of the apoptotic inhibitors Bcl-2-like genes, MCL-1 and BCL-XL, and deletion of apoptotic-promoter genes BOK and PUMA are presented in the somatic copy number variations in over 3000 cancer specimens across 26 human cancer types[83].